the National Key Research and Development Program of China(2016YFC1000805);University Innovation Team Building Program of Chongqing(CXTDG201602020);the Major Project of Military Logistics Research(AWS17J007)
Yu HUANG, Ziwen WANG, Huilan WANG, et al. Fluorescent small molecule IR-61 improves pulmonary fibrosis induced by intratracheal bleomycin in rats[J]. Journal of Third Military Medical University, 2020, 42(4): 350-358.
DOI:
Yu HUANG, Ziwen WANG, Huilan WANG, et al. Fluorescent small molecule IR-61 improves pulmonary fibrosis induced by intratracheal bleomycin in rats[J]. Journal of Third Military Medical University, 2020, 42(4): 350-358. DOI: 10.16016/j.1000-5404.201909108.
Fluorescent small molecule IR-61 improves pulmonary fibrosis induced by intratracheal bleomycin in rats
To evaluate the effects of IR-61 on the development of pulmonary fibrosis and on the proliferation and migration of lung fibroblasts in rats.
Methods
2
Forty male SD rats (6 to 8 weeks old) were randomized equally into normal control group
IR-61 group
bleomycin group and bleomycin+IR-61 group. In the latter 2 groups
rat models of
pulmonary fibrosis were established by intratracheal infusion of bleomycin (2.5 mg/kg). In the 2 groups with IR-61 treatment
IR-61 was intraperitoneally injected at the dose of 2.0 mg/kg 30 min following intratracheal bleomycin infusion and was then administered twice a week. At 10 d after bleomycin treatment
3 rats from each group were selected for IR-61 injection (2 mg/kg)
via
the tail vein to observe the accumulation of IR-61 in each organ at 24 h using near infrared fluorescence imaging (NIR). After 28 d of treatment
the rats were euthanized and the lung tissue was collected for HE and Masson staining. RT-PCR and Western blotting were performed to detect the changes of the expression of the genes related with lung fibroblast transdifferentiation and proliferation (including Collagen-1
Collagen-3
α-SMA
fibronectin
FOXM1
CCNB1
CDC25b and AURKB) in human lung fibroblasts (HFL1) and primary rat lung fibroblasts in response to IR-61 and transforming growth factor-β1 (TGF-β1) treatments; the migration of the cells was assessed using cell scratch test.
Results
2
NIR imaging showed that IR-61 could target the injured lung tissue induced by bleomycin. Morphological observation showed that compared with bleomycin-treated rats
the rats with IR-61 treatment presented with better structural integrity of the lungs with less obvious lung collapse
fewer fibrotic nodules and a significantly milder of pulmonary fibrosis (0.103 3±0.014 53
vs
0.460 0±0.037 86
P
<
0.05). In HFL1 cells and primary rat lung fibroblasts
IR-61 pretreatment prior to TGF-β1 stimulation resulted in significantly lowered mRNA and protein expression of collagen-1
collagen-3
α-SMA
and fibronectin as well as the proliferation-specific genes FOXM1
CCNB1
CDC25b and AURKB (
P
<
0.05). Cell scratch test showed that TGF-β1 treatment significantly increased the cell migration activity
which was effectively suppressed by IR-61 treatment.
Conclusion
2
IR-61 ameliorates bleomycin-induced pulmonary fibrosis in rats by targeting the injured lung tissue and inhibiting the transdifferentiation
proliferation and migration of lung fibroblasts.
关键词
Keywords
references
FANER R, ROJAS M, MACNEE W, et al . Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis[J ] .Am J Respir Crit Care Med, 2012, 186(4): 306-313. DOI:10.1164/rccm.201202-0282PP.
ROCKEY D C, BELL P D, HILL J A. Fibrosis: A common pathway to organ injury andfailure[J]. N Engl J Med, 2015, 372(12): 1138-1149. DOI:10.1056/nejmra1300575.
Selman M, Pardo A.Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model[J]. Am J Respir Crit Care Med, 2014, 189(10): 1161-1172. DOI: 10.1164/rccm.201312-2221PP.
WANG X, CHEN Z L, LUO S L, et al . Development of therapeutic small-moleculefluorophore for cell transplantation[J ] . Adv Funct Mater, 2016, 26(46): 8397-8407. DOI: 10.1002/adfm.201600996.
WILLIS B C, BOROK Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lungdisease[J]. Am J Physiol Lung Cell Mol Physiol, 2007, 293(3): L525-L534. DOI: 10.1152/ajplung.00163.2007.
AL-TAMARI H M, DABRAL S, SCHMALL A, et al . FoxO3 an important player infibrogenesis and therapeutic target for idiopathic pulmonary fibrosis[J ] . EMBO Mol Med, 2018, 10(2): 276-293. DOI: 10.15252/emmm.201606261.
BLACK M, MILEWSKI D, LE T E, et al . FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch inmyofibroblasts[J ] . Cell Rep, 2018, 23(2): 442-458. DOI: 10.1016/j.celrep.2018.03.067.
WYNN T A, RAMALINGAM T R. Mechanisms of fibrosis: therapeutic translation for fibroticdisease[J]. Nat Med, 2012, 18(7): 1028-1040. DOI: 10.1038/nm.2807.
HUANG Y H, ZHOU J, LUO S L, et al . Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial proteintranslocase TIM44[J ] . Gut, 2018, 67(2): 307-319. DOI: 10.1136/gutjnl-2016-311909.
WANG Y, LIAO X Y, SUN J G, et al . Characterization of HIF-1α/glycolysis hyperactive cell population via small-molecule-based imaging of mitochondrialtransporteractivity[J ] . Adv Sci (Weinh), 2018, 5(3): 1700392. DOI: 10.1002/advs.201700392.
WANG Y, LUO S L, ZHANG C, et al . An NIR-fluorophore-based therapeutic endoplasmic reticulum stress inducer[J ] . Adv Mater, 2018, 1:e1800475. DOI: 10.1002/adma.201800475.
JOHNSON N A, SACHINWALLA T, WALTON D W, et al . Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weightloss[J ] . Hepatology, 2009, 50(4): 1105-1112. DOI:10.1002/hep.23129.
ZENG R F, HE Z H, ZHANG X F, et al .Research progress of interstitial transformation of epithelial cells and pulmonary fibrosis[J ] . Contemp Med, 2014, 20(2): 12-13. DOI: 10.3969/j.issn.1009-4393.2014.2.007.